STOCK TITAN

MDB Capital Holdings (MDBH) Stock News, Jan-Jul 2024

MDBH NASDAQ

MDB Capital Holdings, LLC reports developments as a public venture platform and investment holding company focused on launching and supporting disruptive technology companies. Its news commonly covers shareholder updates, operating results, portfolio-company positions, capital-market services and the activity of subsidiaries that combine broker-dealer, intellectual property and technology-development functions.

Company updates also feature PatentVest, MDB’s intellectual property intelligence, strategy and legal-services business. Recurring PatentVest releases discuss IP landscape reports, patent strategy, legal insights, biotechnology and medical-technology collaborations, and equity-linked service engagements that connect patent research, due diligence and venture formation.

Rhea-AI Summary

MDB Capital Holdings (NASDAQ: MDBH) has announced a collaboration with Mayo Clinic to develop a small molecule anti-senescence platform. This partnership targets research in longevity and the prevention of age-related diseases by eliminating senescent cells, which are linked to chronic low-grade inflammation and various age-related diseases, including fibrosis. Mayo Clinic's studies have demonstrated the potential of the molecule to significantly reverse fibrosis. The global market for longevity and anti-senescence therapy is projected to reach $45 billion by 2030. Both MDB's CEO, Christopher Marlett, and Mayo Clinic's Dr. Andrew J. Haak expressed enthusiasm about the collaboration's potential to advance patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
none
-
Rhea-AI Summary

On June 20, 2024, MDB Capital Holdings (NASDAQ: MDBH) announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024. This addition expands the board to eight members. Torpey brings over 24 years of experience from Ernst & Young LLP, specializing in accounting, auditing, compliance, financial reporting, and fraud detection. He has also worked with Arthur Andersen LLP and PricewaterhouseCoopers over his 38-year career. Torpey will soon retire from Ernst & Young and is eager to support MDB Capital's mission of transforming innovative ideas into successful public companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.97%
Tags
management
-
Rhea-AI Summary

PatentVest has released its latest report, 'Pulse of Innovation: Shaping the Future of Cardiac Health Through Technology,' highlighting trends in portable ECG monitoring. The report indicates a 56% increase in global patent publications over the last five years, suggesting a growing market, projected to reach $3 billion annually by 2029. Technological advancements include AI for predictive cardiac risk analysis and integration with telehealth platforms. Major players such as Philips, Huawei, and innovative startups like HeartBeam are competing in this evolving industry. The report provides important insights into the competitive landscape and future trends in cardiac care innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
Rhea-AI Summary

On May 22, 2024, MDB Capital Holdings (NASDAQ: MDBH) announced the unification of its self-clearing broker dealer and online/mobile trading platforms under the single brand name 'MDB Capital.' This change aims to streamline services and enhance clarity for investors, consolidating all offerings on a unified platform. CEO Christopher Marlett emphasized that the rebranding responds to community feedback and is designed to simplify navigation for both prospective and current investors. The new centralized brand is part of MDB's broader mission to transform deep technology 'Big Ideas' into valuable public companies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Summary

Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems, announced the appointment of Michael Heltzen as CEO, and the recent hiring of additional industry veterans for its leadership team. The company filed for an IPO on NASDAQ, offering 4.3 million shares at $4.00 each, aiming for gross proceeds of $17.2 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
management
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.02%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
conferences earnings date
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.46%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.49%
Tags
none

FAQ

What is the current stock price of MDB Capital Holdings (MDBH)?

MDB Capital Holdings (MDBH) last closed at $1.46.

What is the market cap of MDB Capital Holdings (MDBH)?

The market cap of MDB Capital Holdings (MDBH) is approximately $15.2M.